fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » Alkem Laboratories Ltd

Alkem Laboratories Ltd

Updated on October 15, 2020

Stock/Share Code - ALKEM

Alkem Laboratories is a leading Indian Pharmaceutical company with Global operations, engaged in the development, Manufacture and sale of Pharmaceutical and Nutraceutical Products.(Source : 201903 Annual Report Page No: 04)

Below is the details of ALKEM Alkem Laboratories Ltd

Market Cap₹32,554 Cr.
Current Price ₹2,650.8 as on 21 Oct 20
52 Week High / Low Price₹3,090 / ₹1,770
Face Value₹2
Stock P/E22.00
Book Value₹525.27
Dividend Yield0.92 %
ROCE20.33 %
ROE21.48 %
Sales Growth (3yrs)13.65 %
SectorPharmaceuticals
IndustryPharmaceuticals - Indian - Bulk Drugs & Formln
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company has been maintaining a healthy dividend payout of 23.09%
Cons: Promoter holding has decreased by -3.45% over last quarter Tax rate seems low Debtor days have increased from 69.08 to 85.01 days.

Alkem Laboratories Ltd Price Chart

Alkem Laboratories Ltd Price Chart

Alkem Laboratories Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Sun Pharma.Inds. ₹169.4 28.81 ₹124,825.4 Cr. 0.77 -₹1,655.6 Cr. 24.82 -9.42 7585.25 10.53
2. Dr Reddy's Labs ₹5,046.75 36.47 ₹70,902.77 Cr. 0.59 ₹594.6 Cr. -12.11 14.73 4426.50 11.11
3. Cipla ₹767.1 34.95 ₹57,535.92 Cr. 0.42 ₹577.91 Cr. 20.85 8.95 4346.16 11.77
4. Aurobindo Pharma ₹806.2 15.87 ₹47,396.57 Cr. 0.37 ₹780.58 Cr. 20.99 8.82 5924.78 18.73
5. Biocon ₹439.6 70.21 ₹45,138 Cr. 0.13 ₹149.4 Cr. -27.58 14.56 1671.30 13.11
6. Torrent Pharma. ₹50.45 39.86 ₹45,039.6 Cr. 0.64 ₹321 Cr. 48.61 1.68 2056.00 15.01
7. Cadila Health. ₹426.35 26.88 ₹38,006.44 Cr. 0.94 ₹454 Cr. 49.54 4.11 3639.90 11.83
8. Alkem Lab 22.00 ₹32,553.96 Cr. 0.92 ₹426.16 Cr. 102.34 3.49 1550.85 20.33

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Alkem Laboratories Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020
Sales -1,5621,4231,1551,2701,4401,5361,4681,4991,8951,5961,6881,551
YOY Sales Growth %17.67%22.59%14.86%10.96%-7.78%7.94%27.06%18.00%31.55%3.94%14.97%3.49%
Expenses -1,1261,1091,0801,0901,1371,2121,2301,2331,4101,2331,3341,044
Material Cost %37.50%35.77%41.47%38.94%38.47%40.20%41.28%38.13%39.22%34.68%40.45%31.80%
Employee Cost %14.22%15.69%19.01%19.12%15.86%15.89%16.69%18.92%14.54%17.67%13.37%18.34%
Operating Profit43631475180303324238265485364354507
OPM %28%22%7%14%21%21%16%18%26%23%21%33%
Other Income27222519245191331272632
Interest117610971910101012
Depreciation262830323335414040436448
Profit before tax42630164158285287215229465338306479
Tax %22%29%6%18%16%16%11%8%7%-3%11%11%
Net Profit33121360129238241191211434349271426
EPS in Rs27.6617.815.0210.8319.9320.1815.9617.6236.3029.1522.6835.64
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020TTM
Sales -1,1581,3441,6301,9242,2912,6603,0723,9114,5485,2815,7146,6776,729
Sales Growth %18.97%16.03%21.30%18.04%19.07%16.11%15.49%27.29%16.30%16.11%8.20%16.85%
Expenses -1,0131,1361,3191,5181,8622,2622,7273,1803,6684,3084,6675,2095,020
Material Cost %49.22%44.88%43.70%40.24%39.39%43.02%45.53%39.56%39.47%39.30%39.76%38.20%
Manufacturing Cost %6.25%3.47%5.41%6.09%6.05%5.46%4.09%6.96%6.44%6.62%6.47%5.73%
Employee Cost %11.56%14.04%15.44%14.34%16.08%17.05%18.25%16.36%16.20%16.59%17.05%16.04%
Other Cost %20.40%22.11%16.39%18.23%19.76%19.49%20.89%18.43%18.55%19.06%18.38%18.04%
Operating Profit1462083114064293983467318809731,0481,4681,709
OPM %13%15%19%21%19%15%11%19%19%18%18%22%25%
Other Income59781111351681651822401151016696116
Interest15203753798473592432283942
Depreciation212127283643607476108141187195
Profit before tax1692453574604824363958398949349441,3381,589
Tax %6%3%10%6%3%-1%7%17%1%23%15%6%
Net Profit1582383224324674403687008837168001,2641,480
EPS in Rs130.13196.93266.69357.80387.04364.6730.0258.5773.8759.8866.90105.76123.77
Dividend Payout %9%6%6%6%5%5%13%22%20%22%24%24%

Compounded Sales Growth

  • 10 Years:: 17.39%
  • 5 Years:: 16.79%
  • 3 Years:: 13.65%
  • TTM:: 13.24%

Compounded Profit Growth

  • 10 Years:: 18.64%
  • 5 Years:: 30.17%
  • 3 Years:: 12.56%
  • TTM:: 67.99%

Return on Equity

  • 3 Years:: 14.93%
  • 1 Year:: 49.68%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Share Capital -121212121212242424242424
Equity Capital11.9611.9611.9611.9611.9611.9623.9123.9123.9123.9123.9123.91
Reserves9731,1931,4481,8522,2912,7033,0773,5764,3694,8615,4416,257
Borrowings403707288241,2299471,1033803685485031,258
Other Liabilities -2072843834784795406578431,1371,3811,3241,565
Trade Payables112174163259254276347466685819754812
Advance from Customers00523581627252824
Other liability items95110215217222258303360426537542728
Total Liabilities1,5951,5592,5713,1664,0114,2024,8614,8225,8986,8147,2929,104
Fixed Assets -3903924846658329098708751,1261,4711,6061,837
Gross Block4734984846658329091,1569451,2631,7141,9732,352
Accumulated Depreciation83106000028670137243367515
CWIP68000096147218299382314
Investments2620533725799401,0711,1581,5181,5441,6961,956
Other Assets -1,1731,1392,0332,1292,6002,3522,8242,6443,0373,5003,6094,997
Inventories1961762283094535055485908591,0249911,093
Trade receivables1061171622522922903754806338759671,555
Cash Equivalents728662980493965123633524199278398766
Loans n Advances1431971001522371871907681,0381,2731,3411,651
Other asset items0-125639236531,2481,07728130749-89-67
Total Assets1,5951,5592,5713,1664,0114,2024,8614,8225,8986,8147,2929,104

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Cash from Operating Activity -245-8419815297264242630499318745682
Profit from operations1562423314164404053637748901,0121,0741,479
Receivables-8-10-46-90-401-87-129-157-243-104-499
Inventory1020-52-81-144-52-44-42-269-16533-101
Payables56639955981219265200-102149
Loans Advances-13-357-61-84-57-41-3600-3418-145
Other WC items100-4283780071-45-27374032
Working capital changes145-326-67-167-236-32-163-187-512-124-564
Interest paid-1400000000000
Direct taxes-410-67-97-107-109-106-147-205-181-204-234
Cash from Investing Activity -18542-723-279-349119-260311-362-273-313-995
Fixed assets purchased-31-28-117-244-203-97-133-171-460-499-355-282
Fixed assets sold0001133386215
Investments purchased-1940-23-270-27000-42000
Investments sold37520000101023309112953
Investment income000005000000
Interest received3550968515920293148107733540
Dividends received000001010126
Invest in subsidiaries000-39-530-238-59-215-125-174-328
Other investing items00-680188-226-5-8635623917948-498
Cash from Financing Activity --2-2462519274-39526-958-125-60-276173
Proceeds from borrowings1514662944220201-696151880654
Repayment of borrowings0000-17-279-46-26-300-320
Interest paid fin0-20-3700-84-73-53-24-32-28-39
Dividends paid-17-150-53-79-32-57-183-86-216-216-432
Financial liabilities00000000000-11
Other financing items0-30-21-520000000
Net Cash Flow428-6699-10821-128-1713-15156-141

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
ROCE %13%19%22%21%18%15%11%22%21%19%17%20%
Debtor Days343236484640454551606285
Inventory Turnover3.003.403.723.072.512.522.762.812.572.302.352.55

Announcements & News

Recent Announcements

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Alkem Laboratories Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.